France· FR:62232169
HEXATRIONE 2 POUR CENT, suspension injectable (intra-articulaire)
A medicinal product containing hexacétonide de triamcinolone, registered in France by ETHYPHARM, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HEXACÉTONIDE DE TRIAMCINOLONE
- Manufacturer
- ETHYPHARM
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009318413021 ampoule(s) en verre de 2 mlEUR 9.36
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hexacétonide de triamcinolone in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayHexatrioneEthypharm
- SwedenLederspan 20 mg/ml Injektionsvätska, suspensionViatris AB
- FinlandLederspanViatris Oy
- United KingdomLederspan 100mg/5ml suspension for injection vialsWyeth Pharmaceuticals
- CzechiaTRISPANESTEVE Pharmaceuticals GmbH, Berlín
- United StatesHexatrioneMedexus Pharma, Inc.
- IcelandLederlonWilliams & Halls ehf.*
- GermanyLederlonEsteve Pharmaceuticals Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Trispan
- Czechia · Trispan
- Germany · Lederlon
- Denmark · Lederspan, Trica
- Spain · Bluxam
- Finland · Lederspan, Trica
- United Kingdom (Northern Ireland) · Triamcinolone Hexacetonide Trispan
- Iceland · Lederlon, Lederspan
- Netherlands · Trispan
- Norway · Lederspan, Trica
- Portugal · Bluxam
- Sweden · Lederspan, Trica
- Slovenia · Trispan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a7a142f6-23e3-4069-a0c1-8caca9d1a553 GET /v1/drugs/a7a142f6-23e3-4069-a0c1-8caca9d1a553?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62232169",
"date_amm": "1997-12-30",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "HEXACÉTONIDE DE TRIAMCINOLONE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension injectable",
"voies_administration": "intraarticulaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about hexacétonide de triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.